BOUNDLESS BIO, INC.
Last · NASDAQ$2.365-0.025 (-1.05%)live · yahoo · 1h ago
Vol 60.3K ≈ 142.7K
MA10MA20MA50
Market cap$54.65M23.1M sh
P/E · TTM-0.8fwd -2.4 · eps -2.80 · loss
Beta0.47vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.961$3.164
Volume60.3Ksession
Issuer
Legal nameBOUNDLESS BIO, INC.
HQUnited States (US)
ListingUS BOLD
ISINUS10170A1007
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2834
CurrencyUSD
Entity registrysec:0001782303
CIK0001782303
Websitewww.boundlessbio.com
Employees28
AddressBoundless Bio, Inc. North Torrey Pines Road 11099, La Jolla
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-09
From latest 10-K · 2026-03-09
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.4 years
- Accumulated Deficit High — Accumulated deficit / equity 263%
Press & signals
- GlobeNewswire
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement